1. Home
  2. KEX vs BLTE Comparison

KEX vs BLTE Comparison

Compare KEX & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kirby Corporation

KEX

Kirby Corporation

N/A

Current Price

$124.29

Market Cap

7.0B

ML Signal

N/A

Logo Belite Bio Inc

BLTE

Belite Bio Inc

N/A

Current Price

$156.85

Market Cap

6.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KEX
BLTE
Founded
1921
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
6.0B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
KEX
BLTE
Price
$124.29
$156.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
9
Target Price
$174.71
★ $227.44
AVG Volume (30 Days)
★ 670.0K
134.3K
Earning Date
10-28-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 28.92
N/A
EPS
★ 5.26
N/A
Revenue
N/A
N/A
Revenue This Year
$9.72
N/A
Revenue Next Year
$7.09
N/A
P/E Ratio
$23.59
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$105.10
$105.88
52 Week High
$157.69
$200.00

Technical Indicators

Market Signals
Indicator
KEX
BLTE
Relative Strength Index (RSI) 36.86 51.94
Support Level $118.72 $145.61
Resistance Level $142.04 $158.76
Average True Range (ATR) 5.76 7.01
MACD -1.95 1.33
Stochastic Oscillator 19.45 73.84

Price Performance

Historical Comparison
KEX
BLTE

About KEX Kirby Corporation

Kirby Corp is a domestic tank barge operator, transporting bulk liquid products throughout three United States coasts. The Company transports petrochemicals, liquid cargoes, inland waterway systems, and dry bulk cargoes. The Company conducts operations in two reportable business segments: The Marine transportation segment which provides marine transportation services, operating tank barges and towing vessels transporting bulk liquid products, and the Distribution and services segment, which provides after-market service, and genuine replacement parts for engines, transmissions, reduction gears, and power generation equipment used in oil and gas and commercial and industrial applications. The company's majority revenue is generated from the Marine Transportation segment.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

Share on Social Networks: